ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HIV Point-of-care Testing Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-33A866
Home | Market Reports | Health| Reproductive Health
Global HIV Point of care Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global HIV Point-of-care Testing Market Insights, Forecast to 2030

Code: QYRE-Auto-33A866
Report
December 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
BD
Biomerieux
Adaltis
Roche

HIV Point-of-care Testing Market

HIV Point-of-care Testing is used to screen HIV antibodies. They can be performed in hospitals, clinics, and home care settings, and the results of these tests are available within a few minutes.
The global HIV Point-of-care Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global HIV diagnostics market is booming due to rising demand for rapid testing and point-of-care (PoC) HIV tests around the world. In addition, people's disposable income is increasing, which is encouraging the HIV point-of-care testing market growth.
Report Covers:
This report presents an overview of global market for HIV Point-of-care Testing, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of HIV Point-of-care Testing, also provides the sales of main regions and countries. Highlights of the upcoming market potential for HIV Point-of-care Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the HIV Point-of-care Testing sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global HIV Point-of-care Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for HIV Point-of-care Testing sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of HIV Point-of-care Testing Market Report

Report Metric Details
Report Name HIV Point-of-care Testing Market
Segment by Type
  • Testing Equipment
  • Testing Reagent
Segment by Application
  • Hospitals
  • Clinics
  • Home Care Setting
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biomerieux, Adaltis, Roche
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of HIV Point-of-care Testing in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of HIV Point-of-care Testing manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV Point-of-care Testing sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the HIV Point-of-care Testing Market report?

Ans: The main players in the HIV Point-of-care Testing Market are Biomerieux, Adaltis, Roche

What are the Application segmentation covered in the HIV Point-of-care Testing Market report?

Ans: The Applications covered in the HIV Point-of-care Testing Market report are Hospitals, Clinics, Home Care Setting

What are the Type segmentation covered in the HIV Point-of-care Testing Market report?

Ans: The Types covered in the HIV Point-of-care Testing Market report are Testing Equipment, Testing Reagent

1 Study Coverage
1.1 HIV Point-of-care Testing Product Introduction
1.2 Market by Type
1.2.1 Global HIV Point-of-care Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Testing Equipment
1.2.3 Testing Reagent
1.3 Market by Application
1.3.1 Global HIV Point-of-care Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care Setting
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global HIV Point-of-care Testing Sales Estimates and Forecasts 2019-2030
2.2 Global HIV Point-of-care Testing Revenue by Region
2.2.1 Global HIV Point-of-care Testing Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global HIV Point-of-care Testing Revenue by Region (2019-2024)
2.2.3 Global HIV Point-of-care Testing Revenue by Region (2025-2030)
2.2.4 Global HIV Point-of-care Testing Revenue Market Share by Region (2019-2030)
2.3 Global HIV Point-of-care Testing Sales Estimates and Forecasts 2019-2030
2.4 Global HIV Point-of-care Testing Sales by Region
2.4.1 Global HIV Point-of-care Testing Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global HIV Point-of-care Testing Sales by Region (2019-2024)
2.4.3 Global HIV Point-of-care Testing Sales by Region (2025-2030)
2.4.4 Global HIV Point-of-care Testing Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global HIV Point-of-care Testing Sales by Manufacturers
3.1.1 Global HIV Point-of-care Testing Sales by Manufacturers (2019-2024)
3.1.2 Global HIV Point-of-care Testing Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of HIV Point-of-care Testing in 2023
3.2 Global HIV Point-of-care Testing Revenue by Manufacturers
3.2.1 Global HIV Point-of-care Testing Revenue by Manufacturers (2019-2024)
3.2.2 Global HIV Point-of-care Testing Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by HIV Point-of-care Testing Revenue in 2023
3.3 Global Key Players of HIV Point-of-care Testing, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global HIV Point-of-care Testing Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global HIV Point-of-care Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of HIV Point-of-care Testing, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of HIV Point-of-care Testing, Product Offered and Application
3.8 Global Key Manufacturers of HIV Point-of-care Testing, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global HIV Point-of-care Testing Sales by Type
4.1.1 Global HIV Point-of-care Testing Historical Sales by Type (2019-2024)
4.1.2 Global HIV Point-of-care Testing Forecasted Sales by Type (2025-2030)
4.1.3 Global HIV Point-of-care Testing Sales Market Share by Type (2019-2030)
4.2 Global HIV Point-of-care Testing Revenue by Type
4.2.1 Global HIV Point-of-care Testing Historical Revenue by Type (2019-2024)
4.2.2 Global HIV Point-of-care Testing Forecasted Revenue by Type (2025-2030)
4.2.3 Global HIV Point-of-care Testing Revenue Market Share by Type (2019-2030)
4.3 Global HIV Point-of-care Testing Price by Type
4.3.1 Global HIV Point-of-care Testing Price by Type (2019-2024)
4.3.2 Global HIV Point-of-care Testing Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global HIV Point-of-care Testing Sales by Application
5.1.1 Global HIV Point-of-care Testing Historical Sales by Application (2019-2024)
5.1.2 Global HIV Point-of-care Testing Forecasted Sales by Application (2025-2030)
5.1.3 Global HIV Point-of-care Testing Sales Market Share by Application (2019-2030)
5.2 Global HIV Point-of-care Testing Revenue by Application
5.2.1 Global HIV Point-of-care Testing Historical Revenue by Application (2019-2024)
5.2.2 Global HIV Point-of-care Testing Forecasted Revenue by Application (2025-2030)
5.2.3 Global HIV Point-of-care Testing Revenue Market Share by Application (2019-2030)
5.3 Global HIV Point-of-care Testing Price by Application
5.3.1 Global HIV Point-of-care Testing Price by Application (2019-2024)
5.3.2 Global HIV Point-of-care Testing Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada HIV Point-of-care Testing Market Size by Type
6.1.1 US & Canada HIV Point-of-care Testing Sales by Type (2019-2030)
6.1.2 US & Canada HIV Point-of-care Testing Revenue by Type (2019-2030)
6.2 US & Canada HIV Point-of-care Testing Market Size by Application
6.2.1 US & Canada HIV Point-of-care Testing Sales by Application (2019-2030)
6.2.2 US & Canada HIV Point-of-care Testing Revenue by Application (2019-2030)
6.3 US & Canada HIV Point-of-care Testing Market Size by Country
6.3.1 US & Canada HIV Point-of-care Testing Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada HIV Point-of-care Testing Sales by Country (2019-2030)
6.3.3 US & Canada HIV Point-of-care Testing Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe HIV Point-of-care Testing Market Size by Type
7.1.1 Europe HIV Point-of-care Testing Sales by Type (2019-2030)
7.1.2 Europe HIV Point-of-care Testing Revenue by Type (2019-2030)
7.2 Europe HIV Point-of-care Testing Market Size by Application
7.2.1 Europe HIV Point-of-care Testing Sales by Application (2019-2030)
7.2.2 Europe HIV Point-of-care Testing Revenue by Application (2019-2030)
7.3 Europe HIV Point-of-care Testing Market Size by Country
7.3.1 Europe HIV Point-of-care Testing Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe HIV Point-of-care Testing Sales by Country (2019-2030)
7.3.3 Europe HIV Point-of-care Testing Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China HIV Point-of-care Testing Market Size
8.1.1 China HIV Point-of-care Testing Sales (2019-2030)
8.1.2 China HIV Point-of-care Testing Revenue (2019-2030)
8.2 China HIV Point-of-care Testing Market Size by Application
8.2.1 China HIV Point-of-care Testing Sales by Application (2019-2030)
8.2.2 China HIV Point-of-care Testing Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia HIV Point-of-care Testing Market Size by Type
9.1.1 Asia HIV Point-of-care Testing Sales by Type (2019-2030)
9.1.2 Asia HIV Point-of-care Testing Revenue by Type (2019-2030)
9.2 Asia HIV Point-of-care Testing Market Size by Application
9.2.1 Asia HIV Point-of-care Testing Sales by Application (2019-2030)
9.2.2 Asia HIV Point-of-care Testing Revenue by Application (2019-2030)
9.3 Asia HIV Point-of-care Testing Sales by Region
9.3.1 Asia HIV Point-of-care Testing Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia HIV Point-of-care Testing Revenue by Region (2019-2030)
9.3.3 Asia HIV Point-of-care Testing Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America HIV Point-of-care Testing Market Size by Type
10.1.1 Middle East, Africa and Latin America HIV Point-of-care Testing Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America HIV Point-of-care Testing Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America HIV Point-of-care Testing Market Size by Application
10.2.1 Middle East, Africa and Latin America HIV Point-of-care Testing Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America HIV Point-of-care Testing Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America HIV Point-of-care Testing Sales by Country
10.3.1 Middle East, Africa and Latin America HIV Point-of-care Testing Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America HIV Point-of-care Testing Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America HIV Point-of-care Testing Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Overview
11.1.3 Abbott HIV Point-of-care Testing Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Abbott HIV Point-of-care Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 BD
11.2.1 BD Company Information
11.2.2 BD Overview
11.2.3 BD HIV Point-of-care Testing Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 BD HIV Point-of-care Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BD Recent Developments
11.3 Biomerieux
11.3.1 Biomerieux Company Information
11.3.2 Biomerieux Overview
11.3.3 Biomerieux HIV Point-of-care Testing Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Biomerieux HIV Point-of-care Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biomerieux Recent Developments
11.4 Adaltis
11.4.1 Adaltis Company Information
11.4.2 Adaltis Overview
11.4.3 Adaltis HIV Point-of-care Testing Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Adaltis HIV Point-of-care Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Adaltis Recent Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Overview
11.5.3 Roche HIV Point-of-care Testing Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Roche HIV Point-of-care Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Roche Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 HIV Point-of-care Testing Industry Chain Analysis
12.2 HIV Point-of-care Testing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 HIV Point-of-care Testing Production Mode & Process
12.4 HIV Point-of-care Testing Sales and Marketing
12.4.1 HIV Point-of-care Testing Sales Channels
12.4.2 HIV Point-of-care Testing Distributors
12.5 HIV Point-of-care Testing Customers
13 Market Dynamics
13.1 HIV Point-of-care Testing Industry Trends
13.2 HIV Point-of-care Testing Market Drivers
13.3 HIV Point-of-care Testing Market Challenges
13.4 HIV Point-of-care Testing Market Restraints
14 Key Findings in The Global HIV Point-of-care Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Abbott
BD
Biomerieux
Adaltis
Roche
List of Tables
    Table 1. Global HIV Point-of-care Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Testing Equipment
    Table 3. Major Manufacturers of Testing Reagent
    Table 4. Global HIV Point-of-care Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global HIV Point-of-care Testing Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global HIV Point-of-care Testing Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global HIV Point-of-care Testing Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global HIV Point-of-care Testing Revenue Market Share by Region (2019-2024)
    Table 9. Global HIV Point-of-care Testing Revenue Market Share by Region (2025-2030)
    Table 10. Global HIV Point-of-care Testing Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global HIV Point-of-care Testing Sales by Region (2019-2024) & (K Units)
    Table 12. Global HIV Point-of-care Testing Sales by Region (2025-2030) & (K Units)
    Table 13. Global HIV Point-of-care Testing Sales Market Share by Region (2019-2024)
    Table 14. Global HIV Point-of-care Testing Sales Market Share by Region (2025-2030)
    Table 15. Global HIV Point-of-care Testing Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global HIV Point-of-care Testing Sales Share by Manufacturers (2019-2024)
    Table 17. Global HIV Point-of-care Testing Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global HIV Point-of-care Testing Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of HIV Point-of-care Testing, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. HIV Point-of-care Testing Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global HIV Point-of-care Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global HIV Point-of-care Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Point-of-care Testing as of 2023)
    Table 23. Global Key Manufacturers of HIV Point-of-care Testing, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of HIV Point-of-care Testing, Product Offered and Application
    Table 25. Global Key Manufacturers of HIV Point-of-care Testing, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global HIV Point-of-care Testing Sales by Type (2019-2024) & (K Units)
    Table 28. Global HIV Point-of-care Testing Sales by Type (2025-2030) & (K Units)
    Table 29. Global HIV Point-of-care Testing Sales Share by Type (2019-2024)
    Table 30. Global HIV Point-of-care Testing Sales Share by Type (2025-2030)
    Table 31. Global HIV Point-of-care Testing Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global HIV Point-of-care Testing Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global HIV Point-of-care Testing Revenue Share by Type (2019-2024)
    Table 34. Global HIV Point-of-care Testing Revenue Share by Type (2025-2030)
    Table 35. HIV Point-of-care Testing Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global HIV Point-of-care Testing Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global HIV Point-of-care Testing Sales by Application (2019-2024) & (K Units)
    Table 38. Global HIV Point-of-care Testing Sales by Application (2025-2030) & (K Units)
    Table 39. Global HIV Point-of-care Testing Sales Share by Application (2019-2024)
    Table 40. Global HIV Point-of-care Testing Sales Share by Application (2025-2030)
    Table 41. Global HIV Point-of-care Testing Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global HIV Point-of-care Testing Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global HIV Point-of-care Testing Revenue Share by Application (2019-2024)
    Table 44. Global HIV Point-of-care Testing Revenue Share by Application (2025-2030)
    Table 45. HIV Point-of-care Testing Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global HIV Point-of-care Testing Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada HIV Point-of-care Testing Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada HIV Point-of-care Testing Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada HIV Point-of-care Testing Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada HIV Point-of-care Testing Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada HIV Point-of-care Testing Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada HIV Point-of-care Testing Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada HIV Point-of-care Testing Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada HIV Point-of-care Testing Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada HIV Point-of-care Testing Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada HIV Point-of-care Testing Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada HIV Point-of-care Testing Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada HIV Point-of-care Testing Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada HIV Point-of-care Testing Sales by Country (2025-2030) & (K Units)
    Table 60. Europe HIV Point-of-care Testing Sales by Type (2019-2024) & (K Units)
    Table 61. Europe HIV Point-of-care Testing Sales by Type (2025-2030) & (K Units)
    Table 62. Europe HIV Point-of-care Testing Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe HIV Point-of-care Testing Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe HIV Point-of-care Testing Sales by Application (2019-2024) & (K Units)
    Table 65. Europe HIV Point-of-care Testing Sales by Application (2025-2030) & (K Units)
    Table 66. Europe HIV Point-of-care Testing Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe HIV Point-of-care Testing Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe HIV Point-of-care Testing Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe HIV Point-of-care Testing Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe HIV Point-of-care Testing Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe HIV Point-of-care Testing Sales by Country (2019-2024) & (K Units)
    Table 72. Europe HIV Point-of-care Testing Sales by Country (2025-2030) & (K Units)
    Table 73. China HIV Point-of-care Testing Sales by Type (2019-2024) & (K Units)
    Table 74. China HIV Point-of-care Testing Sales by Type (2025-2030) & (K Units)
    Table 75. China HIV Point-of-care Testing Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China HIV Point-of-care Testing Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China HIV Point-of-care Testing Sales by Application (2019-2024) & (K Units)
    Table 78. China HIV Point-of-care Testing Sales by Application (2025-2030) & (K Units)
    Table 79. China HIV Point-of-care Testing Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China HIV Point-of-care Testing Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia HIV Point-of-care Testing Sales by Type (2019-2024) & (K Units)
    Table 82. Asia HIV Point-of-care Testing Sales by Type (2025-2030) & (K Units)
    Table 83. Asia HIV Point-of-care Testing Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia HIV Point-of-care Testing Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia HIV Point-of-care Testing Sales by Application (2019-2024) & (K Units)
    Table 86. Asia HIV Point-of-care Testing Sales by Application (2025-2030) & (K Units)
    Table 87. Asia HIV Point-of-care Testing Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia HIV Point-of-care Testing Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia HIV Point-of-care Testing Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia HIV Point-of-care Testing Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia HIV Point-of-care Testing Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia HIV Point-of-care Testing Sales by Region (2019-2024) & (K Units)
    Table 93. Asia HIV Point-of-care Testing Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America HIV Point-of-care Testing Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America HIV Point-of-care Testing Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America HIV Point-of-care Testing Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America HIV Point-of-care Testing Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America HIV Point-of-care Testing Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America HIV Point-of-care Testing Sales by Country (2025-2030) & (K Units)
    Table 107. Abbott Company Information
    Table 108. Abbott Description and Major Businesses
    Table 109. Abbott HIV Point-of-care Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Abbott HIV Point-of-care Testing Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Abbott Recent Developments
    Table 112. BD Company Information
    Table 113. BD Description and Major Businesses
    Table 114. BD HIV Point-of-care Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. BD HIV Point-of-care Testing Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. BD Recent Developments
    Table 117. Biomerieux Company Information
    Table 118. Biomerieux Description and Major Businesses
    Table 119. Biomerieux HIV Point-of-care Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Biomerieux HIV Point-of-care Testing Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Biomerieux Recent Developments
    Table 122. Adaltis Company Information
    Table 123. Adaltis Description and Major Businesses
    Table 124. Adaltis HIV Point-of-care Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. Adaltis HIV Point-of-care Testing Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Adaltis Recent Developments
    Table 127. Roche Company Information
    Table 128. Roche Description and Major Businesses
    Table 129. Roche HIV Point-of-care Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 130. Roche HIV Point-of-care Testing Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Roche Recent Developments
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. HIV Point-of-care Testing Distributors List
    Table 135. HIV Point-of-care Testing Customers List
    Table 136. HIV Point-of-care Testing Market Trends
    Table 137. HIV Point-of-care Testing Market Drivers
    Table 138. HIV Point-of-care Testing Market Challenges
    Table 139. HIV Point-of-care Testing Market Restraints
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. HIV Point-of-care Testing Product Picture
    Figure 2. Global HIV Point-of-care Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global HIV Point-of-care Testing Market Share by Type in 2023 & 2030
    Figure 4. Testing Equipment Product Picture
    Figure 5. Testing Reagent Product Picture
    Figure 6. Global HIV Point-of-care Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global HIV Point-of-care Testing Market Share by Application in 2023 & 2030
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Home Care Setting
    Figure 11. HIV Point-of-care Testing Report Years Considered
    Figure 12. Global HIV Point-of-care Testing Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global HIV Point-of-care Testing Revenue 2019-2030 (US$ Million)
    Figure 14. Global HIV Point-of-care Testing Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global HIV Point-of-care Testing Revenue Market Share by Region (2019-2030)
    Figure 16. Global HIV Point-of-care Testing Sales 2019-2030 ((K Units)
    Figure 17. Global HIV Point-of-care Testing Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada HIV Point-of-care Testing Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada HIV Point-of-care Testing Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe HIV Point-of-care Testing Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe HIV Point-of-care Testing Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China HIV Point-of-care Testing Sales YoY (2019-2030) & (K Units)
    Figure 23. China HIV Point-of-care Testing Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) HIV Point-of-care Testing Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) HIV Point-of-care Testing Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America HIV Point-of-care Testing Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The HIV Point-of-care Testing Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of HIV Point-of-care Testing in the World: Market Share by HIV Point-of-care Testing Revenue in 2023
    Figure 30. Global HIV Point-of-care Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global HIV Point-of-care Testing Sales Market Share by Type (2019-2030)
    Figure 32. Global HIV Point-of-care Testing Revenue Market Share by Type (2019-2030)
    Figure 33. Global HIV Point-of-care Testing Sales Market Share by Application (2019-2030)
    Figure 34. Global HIV Point-of-care Testing Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada HIV Point-of-care Testing Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada HIV Point-of-care Testing Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada HIV Point-of-care Testing Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada HIV Point-of-care Testing Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada HIV Point-of-care Testing Revenue Share by Country (2019-2030)
    Figure 40. US & Canada HIV Point-of-care Testing Sales Share by Country (2019-2030)
    Figure 41. U.S. HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe HIV Point-of-care Testing Sales Market Share by Type (2019-2030)
    Figure 44. Europe HIV Point-of-care Testing Revenue Market Share by Type (2019-2030)
    Figure 45. Europe HIV Point-of-care Testing Sales Market Share by Application (2019-2030)
    Figure 46. Europe HIV Point-of-care Testing Revenue Market Share by Application (2019-2030)
    Figure 47. Europe HIV Point-of-care Testing Revenue Share by Country (2019-2030)
    Figure 48. Europe HIV Point-of-care Testing Sales Share by Country (2019-2030)
    Figure 49. Germany HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 50. France HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 54. China HIV Point-of-care Testing Sales Market Share by Type (2019-2030)
    Figure 55. China HIV Point-of-care Testing Revenue Market Share by Type (2019-2030)
    Figure 56. China HIV Point-of-care Testing Sales Market Share by Application (2019-2030)
    Figure 57. China HIV Point-of-care Testing Revenue Market Share by Application (2019-2030)
    Figure 58. Asia HIV Point-of-care Testing Sales Market Share by Type (2019-2030)
    Figure 59. Asia HIV Point-of-care Testing Revenue Market Share by Type (2019-2030)
    Figure 60. Asia HIV Point-of-care Testing Sales Market Share by Application (2019-2030)
    Figure 61. Asia HIV Point-of-care Testing Revenue Market Share by Application (2019-2030)
    Figure 62. Asia HIV Point-of-care Testing Revenue Share by Region (2019-2030)
    Figure 63. Asia HIV Point-of-care Testing Sales Share by Region (2019-2030)
    Figure 64. Japan HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 68. India HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America HIV Point-of-care Testing Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America HIV Point-of-care Testing Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America HIV Point-of-care Testing Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America HIV Point-of-care Testing Sales Share by Country (2019-2030)
    Figure 75. Brazil HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries HIV Point-of-care Testing Revenue (2019-2030) & (US$ Million)
    Figure 80. HIV Point-of-care Testing Value Chain
    Figure 81. HIV Point-of-care Testing Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions